Tumor Mutation Burden in NSCLC: Tissue Versus Liquid Biopsy Tumor Mutation Burden in NSCLC: Tissue Versus Liquid Biopsy

Tumor mutation burden may be a promising tool to guide immunotherapy, yet many questions need to be answered before adoption into clinical practice.Translational Lung Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news